SCHEMBL16416767

SCHEMBL16416767

CCc1noc(-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)c1Nc1cccc(OC2CCCCC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPAR1 Q92633 10/20 0.42
▸ LPAR3 Q9UBY5 6/20 0.42
▸ ABCC3 O15438 1/20 0.41
▸ ABCC4 O15439 1/20 0.41
▸ ABCB11 O95342 1/20 0.41
▸ CYP2C8 P10632 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ ABCB4 P21439 1/20 0.41
▸ ABCC2 Q92887 1/20 0.41
▸ SLCO1B3 Q9NPD5 1/20 0.41
▸ SLCO1B1 Q9Y6L6 1/20 0.41
▸ NR1H4 Q96RI1 2/20 0.35
▸ FFAR4 Q5NUL3 5/20 0.35
▸ AKT1 P31749 1/20 0.32
▸ AKT2 P31751 1/20 0.32
▸ APP P05067 1/20 0.31
▸ IDO1 P14902 1/20 0.31
▸ FABP1 P07148 1/20 0.31
▸ FABP4 P15090 1/20 0.31
▸ HSD17B13 Q7Z5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4349 0.90 LPAR1 (0.51) LPAR1LPAR3ABCC3ABCC4ABCB11
SCHEMBL4144 0.88 LPAR1 (0.52) LPAR1LPAR3ABCC3ABCC4ABCB11
SCHEMBL5093 0.84 LPAR1 (0.41) LPAR1LPAR3ABCC3ABCC4ABCB11
SCHEMBL10390 0.82 LPAR1 (0.45) LPAR1LPAR3ABCC3ABCC4ABCB11
SCHEMBL4818 0.82 LPAR1 (0.42) LPAR1LPAR3ABCC3ABCC4ABCB11
SCHEMBL3474 0.81 LPAR1 (0.46) LPAR1LPAR3ABCC3ABCC4ABCB11
SCHEMBL10250 0.80 LPAR1 (0.46) LPAR1LPAR3ABCC3ABCC4ABCB11
SCHEMBL3696 0.79 LPAR1 (0.49) LPAR1LPAR3ABCC3ABCC4ABCB11
SCHEMBL3695 0.79 LPAR1 (0.54) LPAR1LPAR3ABCC3ABCC4ABCB11
SCHEMBL6945 0.78 LPAR1 (0.54) LPAR1LPAR3ABCC3ABCC4ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3024456-A1 COMBINATORIAL METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE Update Pharma Inc. (US) 2016-06-01 — — EP disclosed
WO-2015013581-A1 COMBINATORIAL METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE UPDATE PHARMA INC. (US) 2015-01-29 — — WO disclosed
Send feedback